Those who are non-detectible at
week 4, would even have a lower
relapse figure. And depending on which study your read, those that take the shorter 12 or 16 week course, have either an 80 or 90% chance of SVR. In fact, and I may have missed someone, but I don't remember any geno 2 (or geno 1 for that matter) who took the shorter course that did not SVR. I'm estimating that we've had 4-6 geno 2's reporting the short course and 2 geno 1's.